Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents. - Wikidata - wikimedia - TriplyDB

Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents.

Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents.

http://www.wikidata.org/entity/Q38555082

about

The delivery of therapeutic oligonucleotides Application of nanotechnology to cancer radiotherapy Cancer stem cells and personalized cancer nanomedicine.Polymers in the Co-delivery of siRNA and Anticancer Drugs for the Treatment of Drug-resistant Cancers.The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market.Nano-based delivery of RNAi in cancer therapy.Acid-degradable Dextran as an Image Guided siRNA Carrier for COX-2 Downregulation.A Poly(Propyleneimine) Dendrimer-Based Polyplex-System for Single-Chain Antibody-Mediated Targeted Delivery and Cellular Uptake of SiRNA.The potential of antisense oligonucleotide therapies for inherited childhood lung diseases.Capacity of gold nanoparticles in cancer radiotherapy.

P2860

Q37210936-51199DDE-3032-4B60-B673-C24E8CAB0294 Q37516225-F1C0827A-3E70-49F8-8FDF-33406860C3B1 Q38702970-90F08B57-7556-45CF-8BA0-AAAC21755EFB Q39125540-C3DC9041-4C0E-479D-8D3B-14468F11453E Q39227810-EE2552DA-0506-43EE-B0D7-7FE8657E64AD Q42339315-B1562011-E468-4EEE-AC41-8DD2C45ED1DD Q47106820-DE417303-6394-4059-B9DE-0A1157B60415 Q48092346-1663B9EC-9B40-40EC-BCD6-2CF3126A176B Q50146324-958D22C2-EEC2-4452-B67A-3FE24CD87383 Q53722751-BB389982-1B43-4100-A9A6-FC385C8FBE9C

P2860

Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents.

http://www.wikidata.org/entity/Q38555082

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents.

@en

type

label

Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents.

@en

prefLabel

Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents.

@en

P1433

Q38555082-B33EABE3-B8C7-4329-AFB2-5C9B814D277C

P1476

Q38555082-9D954936-D7FC-40EC-B074-F0AADC1D6C53

P2093

Q38555082-9AFC5213-BB1C-4D67-B8CC-9963D7F6671F

Q38555082-E6F4F731-E8EA-46D8-A56B-CCA9CE2958BF

P2860

Q38555082-074399EA-FCFE-4395-A1C4-816D78115663

Q38555082-0A4179F5-75BD-452B-A846-61563AD34D94

Q38555082-0D89684D-21A0-4069-A6C6-F89800FE7AEB

Q38555082-0DA2A5FF-0566-43C1-AFB6-0AC19838A46A

Q38555082-0F9E95BB-6EDA-49AC-BDE3-B8689D0B6CC8

Q38555082-0FCDFC76-EE86-4641-9FFC-01E23FCFC311

Q38555082-17092514-4EEB-4FE8-8729-5F162092E8B5

Q38555082-18C3B35F-592E-4E3A-9064-A59711BD92F5

Q38555082-1A5D79E3-A140-4F87-883A-036D363157B6

Q38555082-1BD30B3A-B55F-43D8-9AB7-A18165AF277F

P304

Q38555082-1FB8EBB4-4A09-4320-8E26-53BA9D19027A

P31

Q38555082-16B4C8A6-C9ED-4C54-B3BF-40A4DD9B2964

P356

Q38555082-F73425CE-F572-4A35-940D-D3CEE5124BBF

P433

Q38555082-34FA7F4E-FF77-4C1B-8A21-8C8823598DD0

P478

Q38555082-C435433C-2BF4-43E8-A09E-9C182A309181

P577

Q38555082-D1A6511D-275B-489D-B611-0E83005611C2

P698

Q38555082-38B27A02-1074-4D34-A4EA-F68872B9A871

P921

Q38555082-8D4ABF6F-6775-4102-BDE9-7836C23B04F2

P356

P1433

P1476

Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents.

@en

P2093

Jing Zhao

http://www.w3.org/2001/XMLSchema#string

Si-Shen Feng

http://www.w3.org/2001/XMLSchema#string

P2860

Nanomaterials based on DNA

The emerging field of RNA nanotechnology

The promises and pitfalls of RNA-interference-based therapeutics

Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities

Cancer treatment and survivorship statistics, 2012

Challenges and opportunities for structural DNA nanotechnology

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

5'-Triphosphate RNA is the ligand for RIG-I

P304

2199-2228

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/NNM.15.61

http://www.w3.org/2001/XMLSchema#string

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26214357

http://www.w3.org/2001/XMLSchema#string

P921